Chinese General Practice ›› 2023, Vol. 26 ›› Issue (18): 2183-2189.DOI: 10.12114/j.issn.1007-9572.2022.0834
Special Issue: 儿科最新文章合辑
• Review & Perspectives • Next Articles
Received:
2022-12-18
Revised:
2023-02-17
Published:
2023-06-20
Online:
2022-12-20
Contact:
HUANG Guanhua
通讯作者:
黄冠华
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0834
血压分类 | 对应血压值 |
---|---|
正常血压 | <P90 |
正常高值血压 | P90~P95或≥120/80 mm Hg |
1级高血压 | (P95~P99)+5 mm Hg |
2级高血压 | ≥P99+5 mm Hg |
Table 1 Classification method of blood pressure of children and adolescents in 2018 Chinese Guidelines for the Management of Hypertension
血压分类 | 对应血压值 |
---|---|
正常血压 | <P90 |
正常高值血压 | P90~P95或≥120/80 mm Hg |
1级高血压 | (P95~P99)+5 mm Hg |
2级高血压 | ≥P99+5 mm Hg |
血压分类 | 1~<13岁 | ≥13岁 |
---|---|---|
正常血压 | <P90 | <120/<80 mm Hg |
血压升高 | P90~<P95或120/80 mm Hg~P95(以较低者为准) | 120~129 mm Hg/<80 mm Hg |
1级高血压 | ≥P95~P95+12 mm Hg或130/80 mm Hg~139/89 mm Hg(以较低者为准) | 130/80 mm Hg~139/89 mm Hg |
2级高血压 | ≥P95+12 mm Hg或≥140/90 mm Hg(以较低者为准) | ≥140/90 mm Hg |
Table 2 Classification method of blood pressure of children and adolescents in Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents published by American Academy of Pediatrics
血压分类 | 1~<13岁 | ≥13岁 |
---|---|---|
正常血压 | <P90 | <120/<80 mm Hg |
血压升高 | P90~<P95或120/80 mm Hg~P95(以较低者为准) | 120~129 mm Hg/<80 mm Hg |
1级高血压 | ≥P95~P95+12 mm Hg或130/80 mm Hg~139/89 mm Hg(以较低者为准) | 130/80 mm Hg~139/89 mm Hg |
2级高血压 | ≥P95+12 mm Hg或≥140/90 mm Hg(以较低者为准) | ≥140/90 mm Hg |
血压分类 | 1~15岁 | ≥16岁 |
---|---|---|
正常血压 | <P90 | <130/85 mm Hg |
血压升高 | P90~<P95 | 130~139 mm Hg/85~89 mm Hg |
高血压 | ≥P95 | ≥140/90 mm Hg |
1级高血压 | ≥P95~P99+5 mm Hg | 140~159 mm Hg/90~99 mm Hg |
2级高血压 | ≥P99+5 mm Hg | 160~179 mm Hg/100~109 mm Hg |
单纯收缩期高血压 | 收缩压≥P95且舒张压<P90 | 收缩压≥140 mm Hg且舒张压<90 mm Hg |
Table 3 Classification method of blood pressure of children and adolescents in 2016 European Society of Hypertension Guidelines for the Management of High Blood Pressure in Children and Adolescents
血压分类 | 1~15岁 | ≥16岁 |
---|---|---|
正常血压 | <P90 | <130/85 mm Hg |
血压升高 | P90~<P95 | 130~139 mm Hg/85~89 mm Hg |
高血压 | ≥P95 | ≥140/90 mm Hg |
1级高血压 | ≥P95~P99+5 mm Hg | 140~159 mm Hg/90~99 mm Hg |
2级高血压 | ≥P99+5 mm Hg | 160~179 mm Hg/100~109 mm Hg |
单纯收缩期高血压 | 收缩压≥P95且舒张压<P90 | 收缩压≥140 mm Hg且舒张压<90 mm Hg |
血压分类 | 6~11岁 | 12~17岁 |
---|---|---|
高血压 | >120/80 mm Hg或≥P95 | >130/85 mm Hg或≥P95 |
1级高血压 | P95~P95+12 mm Hg | P95~P95+12 mm Hg |
2级高血压 | >P95+12 mm Hg | >P95+12 mm Hg |
Table 4 Classification method of blood pressure of children and adolescents in Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention,Diagnosis,Risk Assessment,and Treatment of Hypertension in Adults and Children
血压分类 | 6~11岁 | 12~17岁 |
---|---|---|
高血压 | >120/80 mm Hg或≥P95 | >130/85 mm Hg或≥P95 |
1级高血压 | P95~P95+12 mm Hg | P95~P95+12 mm Hg |
2级高血压 | >P95+12 mm Hg | >P95+12 mm Hg |
[1] |
|
[2] |
中国高血压防治指南修订委员会,高血压联盟(中国),中华医学会心血管病学分会中国医师协会高血压专业委员会,等. 中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志,2019,24(1):24-56. DOI:10.3969/j.issn.1007-5410.2019.01.002.
|
[3] |
米杰,王天有,孟玲慧,等. 中国儿童青少年血压参照标准的研究制定[J]. 中国循证儿科杂志,2010,5(1):4-14. DOI:10.3969/j.issn.1673-5501.2010.01.002.
|
[4] |
|
[5] |
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis,evaluation,and treatment of high blood pressure in children and adolescents[J]. Pediatrics,2004,114(2 Suppl 4th Report):555-576.
|
[6] |
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[34] |
|
[35] |
|
[36] |
|
[37] |
|
[38] |
|
[39] |
|
[40] |
Chronic Kidney Disease Prognosis Consortium,
|
[41] |
|
[42] |
|
[43] |
|
[44] |
|
[45] |
|
[46] |
|
[47] |
|
[48] |
|
[49] |
|
[50] |
|
[1] | TIAN Chen, LIU Jianing, TIAN Jinhui, GE Long. Living Systematic Reviews: Methods and Processes for Development [J]. Chinese General Practice, 2025, 28(30): 3853-3860. |
[2] | WANG Tingting, TANG Yong, ZHANG Wenke, LI Zhigang. Research Progress on Exercise Intervention of Hyperuricemia [J]. Chinese General Practice, 2025, 28(30): 3841-3846. |
[3] | WU Wenjun, WEI Jingjing, LI Xue, REN Hongjie, YU Rui, PENG Guangcao, ZHU Mingjun. Regularity of Prescriptions for Coronary Heart Disease with Hypertension Based on Latent Structure and Association Rules [J]. Chinese General Practice, 2025, 28(30): 3787-3795. |
[4] | BAI Jiaxin, CHEN Yu, ZHOU Yiheng, LIU Lidi, YANG Rong, YAO Yi, YUAN Bo, ZHANG Yonggang, LEI Yi, ZENG Rui, JIA Yu, LIAO Xiaoyang. Assessment and Treatment of Early-onset Hypertension: Position Statement of the British and Irish Hypertension Association and Its Implications for Clinical Management of Early-onset Hypertension in China [J]. Chinese General Practice, 2025, 28(30): 3741-3746. |
[5] | QIN Bangguo, SUN Jin, LI Man, QIU Jiaojiao, CHENG Bokai, ZHU Ping, WANG Shuxia. Relationship between Non-high-density Lipoprotein Cholesterol to High-density Lipoprotein Cholesterol Ratio and Left Ventricular Hypertrophy in a Community-based Hypertensive Population [J]. Chinese General Practice, 2025, 28(30): 3753-3760. |
[6] | ZHOU Sheng, DENG Changsheng, ZOU Guanyang, SONG Jianping. Research Progress on the Pathogenesis of Complications of Malaria in Cardiovascular Diseases [J]. Chinese General Practice, 2025, 28(27): 3466-3472. |
[7] | HUANG Yulin, WANG Haoyun, LI Yanmei, XIAO Xueying. Symptom Clusters in Gastric Cancer Patients Receiving Chemotherapy: a Scoping Review [J]. Chinese General Practice, 2025, 28(26): 3338-3344. |
[8] | HAN Xiao, LI Qiyu, GE Pu, FAN Siyuan, LIU Diyue, WU Yibo, ZHANG Qingshuang. The Impact of Behavioral Lifestyle on Quality of Life in Hypertensive Patients [J]. Chinese General Practice, 2025, 28(26): 3248-3258. |
[9] | YU Zizi, LIU Duli, LI Ximin, RUAN Chunyi, YIN Xiangyang, CAI Le. Analysis of the Prevalence and Self-management of Hypertension and Its Influencing Factors in Rural [J]. Chinese General Practice, 2025, 28(25): 3137-3143. |
[10] | TANG Shangfeng, HUANG Yangzhen, PAN Yangyang, ZHENG Yanxi, XIONG Zhongbao, ZHANG Kangkang, SONG Jia, WEI Yilin, WANG Chunying, DONG Heng, CHEN Manwei, QING Hua. Specification for the Integration of Healthcare and Prevention Services in Hypertension at the Primary Level [J]. Chinese General Practice, 2025, 28(25): 3089-3095. |
[11] | LIU Yinyin, SUI Hongping, LI Tingting, JIANG Tongtong, SHI Tieying, XIA Yunlong. Advances in Risk Prediction Models for Cardiotoxicity Associated with Breast Cancer Treatment [J]. Chinese General Practice, 2025, 28(24): 3072-3078. |
[12] | LI Miaoxiu, ZHU Bowen, KONG Lingjun, FANG Min. Progress in Research on Clinical Assessment Tools for Conservative Treatment of Adolescent Idiopathic Scoliosis [J]. Chinese General Practice, 2025, 28(24): 3079-3088. |
[13] | WEI Yunhong, YANG Li, WANG Yulu, YE Qiufang, DAI Anni, HE Yan. Study on Cardiopulmonary Function During Different Exercise Stages in Patients with Obesity-related Hypertension [J]. Chinese General Practice, 2025, 28(24): 2972-2978. |
[14] | XIAO Yao, WAN Jun. Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants [J]. Chinese General Practice, 2025, 28(24): 3066-3071. |
[15] | HE Jinyu, ZHULIDUZI Jiesisibieke, ZHANG Ning, LIU Min, LIANG Wannian. Research on Blood Pressure Control and Its Determinants Among Hypertensive Patients Under Standardized Management in China: Status, Challenges, and Future Directions [J]. Chinese General Practice, 2025, 28(24): 2968-2971. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||